Grn Frontotemporal Dementia

News

January 29, 2024

1 min read

Save

Vesper Bio secures $873K grant from Michael J. Fox Foundation

A clinical stage biotech company has been awarded a grant for $873,000 by The Michael J. Fox Foundation for Parkinson’s Research to help assess sortilin inhibition in Parkinson’s disease.